December 15, 2021

Alverno Laboratories has issued important updates for healthcare providers. Firstly, tissue culture processing protocols have changed, with E-swabs no longer accepted for solid tissue specimens due to processing limitations; instead, tissue cultures must be sent in sterile containers with saline. Secondly, there are updated CBC reference ranges for pediatric patients, categorized by age and gender. Lastly, Alverno is replacing the Pain Management Panel with a more extensive Extensive Urine Drug Confirmation Panel, offering lower reporting limits and additional analytes tested via Liquid Chromatography Mass Spectrometry, useful for both pain management and behavioral health analysis. These updates aim to improve testing accuracy and provide comprehensive information for patient care.